User profiles for Francois Benard

François Bénard

Professor of Radiology, University of British Columbia
Verified email at bccrc.ca
Cited by 11091

Respiratory gating for 3-dimensional PET of the thorax: feasibility and initial results

…, S Rodrigue, R Lecomte, F Bénard - Journal of Nuclear …, 2004 - Soc Nuclear Med
Respiratory motion may reduce the sensitivity of 18 F-FDG PET for the detection of small
pulmonary nodules close to the base of the lungs. This motion also interferes with attempts to …

F-18-fluorodeoxyglucose positron emission tomography imaging-assisted management of patients with severe left ventricular dysfunction and suspected coronary …

…, R dekemp, A Guo, TD Ruddy, F Benard… - Journal of the American …, 2007 - jacc.org
Objectives : We conducted a randomized trial to assess the effectiveness of F-18-fluorodeoxyglucose
(FDG) positron emission tomography (PET)-assisted management in patients with …

[HTML][HTML] Structure and activity of human TMPRSS2 protease implicated in SARS-CoV-2 activation

…, L Halabelian, CH Arrowsmith, F Bénard - Nature chemical …, 2022 - nature.com
Transmembrane protease, serine 2 (TMPRSS2) has been identified as key host cell factor
for viral entry and pathogenesis of SARS-CoV-2. Specifically, TMPRSS2 proteolytically …

Prognostic value of FDG PET imaging in malignant pleural mesothelioma

F Bénard, D Sterman, RJ Smith… - The Journal of Nuclear …, 1999 - search.proquest.com
Despite several attempts at treating malignant pleural mesothelioma with various modalities,
mortality remains high, with median survival between 12 and 18 mo. This disease may …

[HTML][HTML] Metabolic imaging of malignant pleural mesothelioma with fluorodeoxyglucose positron emission tomography

F Bénard, D Sterman, RJ Smith, LR Kaiser, SM Albelda… - Chest, 1998 - Elsevier
Background:The diagnosis of malignant mesothelioma is a challenging medical problem.
CT often cannot differentiate between benign diffuse pleural thickening and malignant …

Dual time point fluorine-18 fluorodeoxyglucose positron emission tomography: a potential method to differentiate malignancy from inflammation and normal tissue in …

R Hustinx, RJ Smith, F Benard, DI Rosenthal… - European journal of …, 1999 - Springer
Fluorine-18 fluorodeoxyglucose (FDG) positron emission tomography (PET) studies imaging
FDG PET imaging is used to detect and stage head and neck cancers. However, the …

[PDF][PDF] A nomogram predicting 10-year life expectancy in candidates for radical prostatectomy or radiotherapy for prostate cancer

…, SF Shariat, C Jeldres, M Graefen, F Bénard… - Journal of Clinical …, 2007 - Citeseer
Purpose Candidates for definitive therapy for localized prostate cancer (PCa) should have
life expectancy (LE) in excess of 10 years. However, LE estimation is difficult. To circumvent …

Prognostic value of PET using 18F-FDG in Hodgkin's disease for posttreatment evaluation

…, M Lépine, J Verreault, F Bénard - Journal of Nuclear …, 2003 - Soc Nuclear Med
Detection of relapse after completion of therapy in patients with Hodgkin’s disease (HD) and
non-Hodgkin’s lymphomas (NHL) constitutes an important challenge in modern medical …

An Organotrifluoroborate for Broadly Applicable One‐Step 18F‐Labeling

…, J Pan, GM Dias, D Yapp, KS Lin, F Bénard… - Angewandte …, 2014 - Wiley Online Library
A new zwitterionic organotrifluoroborate is appended to three radiosynthons that afford
undergo facile bioconjugation to several clinically relevant peptides and one enzyme inhibitor. …

Increasing benefit from revascularization is associated with increasing amounts of myocardial hibernation: a substudy of the PARR-2 trial

…, M Freeman, N Racine, F Benard… - JACC: Cardiovascular …, 2009 - jacc.org
Objectives : We sought to determine: 1) whether F-18-fluorodeoxyglucose (FDG) positron
emission tomography (PET) parameters identify high-risk patients who gain benefit from …